Author
Listed:
- Xinbo Yang
(Stanford University School of Medicine
Stanford University School of Medicine)
- Lee I. Garner
(University of Oxford
Centre for Immuno-oncology, Nuffield Department of Medicine, University of Oxford)
- Ivan V. Zvyagin
(Pirogov Russian National Research Medical University
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry)
- Michael A. Paley
(Washington University School of Medicine)
- Ekaterina A. Komech
(Pirogov Russian National Research Medical University
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry)
- Kevin M. Jude
(Stanford University School of Medicine
Stanford University School of Medicine)
- Xiang Zhao
(Stanford University School of Medicine
Stanford University School of Medicine)
- Ricardo A. Fernandes
(Stanford University School of Medicine
Stanford University School of Medicine)
- Lynn M. Hassman
(Washington University School of Medicine)
- Grace L. Paley
(Washington University School of Medicine)
- Christina S. Savvides
(Stanford University School of Medicine
Stanford University School of Medicine)
- Simon Brackenridge
(University of Oxford
Centre for Immuno-oncology, Nuffield Department of Medicine, University of Oxford)
- Max N. Quastel
(University of Oxford
Centre for Immuno-oncology, Nuffield Department of Medicine, University of Oxford)
- Dmitriy M. Chudakov
(Pirogov Russian National Research Medical University
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry)
- Paul Bowness
(University of Oxford)
- Wayne M. Yokoyama
(Washington University School of Medicine
Washington University School of Medicine)
- Andrew J. McMichael
(University of Oxford
Centre for Immuno-oncology, Nuffield Department of Medicine, University of Oxford)
- Geraldine M. Gillespie
(University of Oxford
Centre for Immuno-oncology, Nuffield Department of Medicine, University of Oxford)
- K. Christopher Garcia
(Stanford University School of Medicine
Stanford University School of Medicine
Stanford University School of Medicine)
Abstract
Human leucocyte antigen B*27 (HLA-B*27) is strongly associated with inflammatory diseases of the spine and pelvis (for example, ankylosing spondylitis (AS)) and the eye (that is, acute anterior uveitis (AAU))1. How HLA-B*27 facilitates disease remains unknown, but one possible mechanism could involve presentation of pathogenic peptides to CD8+ T cells. Here we isolated orphan T cell receptors (TCRs) expressing a disease-associated public β-chain variable region–complementary-determining region 3β (BV9–CDR3β) motif2–4 from blood and synovial fluid T cells from individuals with AS and from the eye in individuals with AAU. These TCRs showed consistent α-chain variable region (AV21) chain pairing and were clonally expanded in the joint and eye. We used HLA-B*27:05 yeast display peptide libraries to identify shared self-peptides and microbial peptides that activated the AS- and AAU-derived TCRs. Structural analysis revealed that TCR cross-reactivity for peptide–MHC was rooted in a shared binding motif present in both self-antigens and microbial antigens that engages the BV9–CDR3β TCRs. These findings support the hypothesis that microbial antigens and self-antigens could play a pathogenic role in HLA-B*27-associated disease.
Suggested Citation
Xinbo Yang & Lee I. Garner & Ivan V. Zvyagin & Michael A. Paley & Ekaterina A. Komech & Kevin M. Jude & Xiang Zhao & Ricardo A. Fernandes & Lynn M. Hassman & Grace L. Paley & Christina S. Savvides & S, 2022.
"Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides,"
Nature, Nature, vol. 612(7941), pages 771-777, December.
Handle:
RePEc:nat:nature:v:612:y:2022:i:7941:d:10.1038_s41586-022-05501-7
DOI: 10.1038/s41586-022-05501-7
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:612:y:2022:i:7941:d:10.1038_s41586-022-05501-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.